Tag Archives: webinar

July 2014 Webinar – The Latest News About CRC Research & Treatment

Learn the latest findings from the American Society of Clinical Oncology (ASCO) conference in May. The latest studies, treatments and developments and how they impact colorectal cancer patients were discussed. PRESENTED BY: Cathy Eng, M.D. Associate Professor, Department of Gastrointestinal (GI) Medical OncologyDr. Cathy Eng is Associate Professor in the Department of Gastrointestinal (GI) Medical Oncology at The University of Texas M. D. Anderson Cancer Center. Dr. Eng received her medical degree from Hahnemann University School of Medicine in Philadelphia, PA, followed by an internship and residency at Rush-Presbyterian St. Luke’s Medical Center in Chicago, IL. She went on to complete a fellowship in Hematology/Oncology at University of Chicago Medical Center. Dr. Eng is board certified in

Webinar Wrap-Up – Family First – Genetic Syndromes by Heather Hampel

Patients, caregivers and family members use our webinars each month to learn more about the battle against colorectal cancer and find the news they need to stay informed. At Fight Colorectal Cancer, we believe that education empowers those affected by colorectal cancer to take control of their lives. Below is Q&A with Heather Hampel, our presenter of the webinar “Family First: What You Need To Know About Genetic Testing, Family History & Colorectal Cancer.“   Q&A with Heather Q: I would like to know when my children need to start getting colonoscopies. (They’re 32 and 25). Also would like to know if there is any connection, at all, between an astrocytoma brain tumor and

May 2014 Webinar: Family First – What You Need to Know About Family History & Colorectal Cancer

Have you and your family discussed your family’s medical history? Did you know that 10-15% of all cancers are familial, and 3% of all colorectal cancers are due to a syndrome called Lynch Syndrome? Having Lynch Syndrome puts you at an 80% increased risk of developing colorectal cancer. Tune into this webinar to learn more about Lynch Syndrome and other inherited syndromes as they relate to colorectal cancer. Presented by: Heather Hampel, MS, CGC Ohio State University Comprehensive Cancer Center Ms. Hampel has been a cancer genetic counselor since 1995 and is a faculty member in the Division of Human Genetics. Her clinical duties include providing comprehensive cancer genetic consultations to

April 2014 Webinar: Alphabet Soup – Making Sense out of KRAS, BRAF and Tumor Tests

Have you ever heard any of these acronyms, and wondered what they stand for and how they can affect your treatment plan?  This webinar is designed to help patients better understand biomarkers, and how these biomarkers can affect the treatment options patients receive. We’ll discuss the basic understandings of a cancer cell lives, and how it dies.  As researchers are learning more and more about how to treat colorectal cancer, it is bringing the meaning of truly personalized medicine to the forefront. Join us to learn more, and how this research may affect your overall treatment plan. Presented by: Cathy Eng, M.D. Associate Professor, Department of Gastrointestinal (GI) Medical Oncology Dr.

February 2014 Webinar -RESEARCH & TREATMENT NEWS: Highlights from the 2014 GI Cancer Symposium

Each January, the brightest minds in colorectal cancer research meet at the Gastrointestinal Cancer Symposium. Fight Colorectal Cancer and The Colon Cancer Alliance are partnering to bring you the big news in colorectal cancer from the symposium. Dr. Allyson Ocean will be presenting your options for treatment and know that you are not alone in your diagnosis. The material with the combined audio will be available at CCA’s website. To hear the presentation, listen to what Dr. Ocean said on our audio library.

January 2014 Webinar – After The Shock: A CRC Diagnosis

Have you or someone you love recently been diagnosed with stage III or stage IV colorectal cancer? Feeling overwhelmed? Learn where to go from here. We’ll talk about every leg of the journey from understanding your diagnosis to tips on building your treatment team. Join us and Dr. Edward Crane to better understand your options for treatment and know that you are not alone in your diagnosis. View/download the slides from the Jan. 22 webinar: Read the TweetUp recap on Storify. 

WEBINAR: Molecular Testing & Tumor Testing

Molecular testing and tumor testing — ever heard about it? Ever been asked about it? Join us for a Webinar on Wednesday, July 17 (8-9:30pm EDT) to learn more about these tools available for colorectal cancer patients. We’ll discuss: The importance of tumor testing and molecular testing. How this testing relates to colon and rectal cancer. If you should have your tumor tested. What tumor testing involves and how tumor testing is performed. The role tumor testing plays in a patient’s treatment options. Physicians making treatment choices based on a tumor’s molecular biology. REGISTER NOW About the presenter: Dr. Bekaii-Saab is the Section Chief, Gastrointestinal Oncology at James Cancer Hospital

What’s New & What’s On the Horizon in Colon Cancer?

Are you a patient, caregiver, survivor or advocate interested in all things colorectal cancer? Want to be “in the know?” Then make sure to join our FREE June webinar, What’s New & What’s on the Horizon. In partnership with Colon Cancer Alliance (CCA), we will present some of the latest information regarding colorectal cancer. Representatives from both CCA and Fight Colorectal Cancer attended the 2013 Gastrointestinal Cancers Symposium co-sponsored by the American Society of Clinical Oncology®. Our teams will report on the latest news in cancer research and care. Our webinar will touch on: the key 2013 colorectal cancer findings updates on FDA-approved drugs for colorectal cancer information about what’s next for colorectal cancer

Experts Issue Practice-Changing Advice: Stop giving calcium/magnesium for oxaliplatin-caused neuropathy

For patients getting the common FOLFOX chemotherapy for colorectal cancer, many oncologists add intravenous calcium and magnesium, hoping to decrease the neuropathy (nerve damage) associated with oxaliplatin-based drugs. But this week, experts at the 2013 ASCO meeting (American Society of Clinical Oncology), announced strong evidence that the calcium/magnesium does no good in either preventing or decreasing neuropathy—and it should no longer be part of routine treatment. Neuropathy affects cancer treatment Oxaliplatin-based chemotherapy (e.g. FOLFOX, with Eloxatin®) is one of the most commonly used drugs for people having high-risk stage II, or stages III or IV colorectal cancer. But far too often after patients have had many doses of FOLFOX over

Top